Skip to main content
. Author manuscript; available in PMC: 2011 Dec 15.
Published in final edited form as: Int J Pharm. 2010 Sep 29;402(1-2):190–197. doi: 10.1016/j.ijpharm.2010.09.015

Figure 4.

Figure 4

Plasma cytokine levels 24 hours following single dose i.v. administration of various pSi S1MP nanovectors. The treatments included saline, silicic acid equivalent to the 5×108 of the particles injected, negatively (oxidized) and positively (APTES) charged S1MP particles at the doses of 107, 108 and 5×108 particles per mouse. The results are presented as mean ± S.D (n=4–6)